Imaginostics Participates in Start-Up Forum at The Alzheimer’s Drug Discovery Foundation Annual Conference

Imaginostics participated in a start-up forum hosted by The Alzheimer’s Drug Discovery Foundation (ADDF) at their annual conference. CEO Codi Gharagouzloo, PhD, represented Imaginostics, as part of a forum that included other innovative start-ups from around the United States, Canada, and Europe. The annual conference brings together scientists from industry and academia and other professionals committed to drug discovery and related research on Alzheimer’s disease. It is hosted by the Alzheimer’s Drug Discovery Foundation (ADDF) and seeks “to accelerate the development of innovative treatments for Alzheimer’s disease, related dementias and cognitive aging.” Founded in 1998, ADDF focuses on finding treatments for Alzheimer’s and the translation of knowledge on the disease to treatments with particular focus on promising but underfunded areas of research.

Details on the Conference can be found here: https://meetings.alzdiscovery.org/alz-program/

To read about ADDF, please see: https://www.alzdiscovery.org/about-addf